KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Phase One Labz: 18 Kovera certificates.
The lab's record shows 18 certificates printed for Phase One Labz, analysed between 7 May 2026 and 8 May 2026, covering 16 products. Median HPLC purity is 99.89%. Kovera graded 17 as a pass and 0 as a fail; 1 carry no verdict.
18
certificates
99.89%
median purity
16
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 18 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 5 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
16 AS PRINTEDP1-RT3 · 2P1-TZ-2 · 2BPC-157 · 1BPC-157/TB-500 · 1CJC-1295 (No DAC)/Ipamorelin · 1GHK-Cu · 1Glow · 1Klow · 1KPV · 1Lipo-C + B12 · 1Lipo-C/B12 · 1MOTS-c · 1MT II · 1NAD+ · 1TB-500 (Thymosin B4) · 1Tesamorelin · 1
Every certificate
NEWEST FIRST · 18 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| LIPOC-KVR-2026-08234E | Lipo-C + B12lipo c certificate | CP10-03262026 | — | — | 8 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-08234E | Lipo-C/B12 | CP10-03262026 | 99.891% | 100.8%10.08 of 10 mg | 8 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-C9A3B1 | BPC-157/TB-500 | BB20-03242026 | 99.721% | 111.3%22.26 of 20 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C4E12A | Tesamorelin | TESA10-03112026 | 99.943% | 117.6%11.76 of 10 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C184DC | P1-RT3 | RT10-1025 | 99.847% | 105.7%10.57 of 10 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-BD77F1 | CJC-1295 (No DAC)/Ipamorelin | CP10-03262026 | 99.813% | 112.6%11.26 of 10 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-BB9717 | MT II | MLT210-02242026 | 99.922% | 98.2%9.82 of 10 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-84F6DF | TB-500 (Thymosin B4) | TB510-03102026 | 99.841% | 98.1%9.81 of 10 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-792A96 | Klow | KLOW-03162026 | 99.781% | 109.4%87.55 of 80 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-47351F | P1-TZ-2 | ION2T10-03102026 | 99.987% | 108.6%10.86 of 10 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-44F549 | BPC-157 | BC10-03192026 | 99.912% | 114.2%11.42 of 10 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-417D74 | KPV | KPV10-03102026 | 99.853% | 94.8%9.48 of 10 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-3D1A4B | NAD+ | ND5-011726 | 99.904% | 96.6%482.93 of 500 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-240267 | MOTS-c | MC10-03102026 | 99.983% | 106.6%10.66 of 10 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-161D8C | P1-TZ-2 | ION2T20-03102026 | 99.938% | 111.2%22.23 of 20 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-0DF2F1 | GHK-Cu | GU50-03112026 | 99.981% | 102.5%51.26 of 50 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-0829A8 | Glow | GLOW-03162026 | 99.743% | 105.7%73.97 of 70 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-068BE7 | P1-RT3 | GP3R30-01152026 | 99.856% | 106.2%31.86 of 30 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |